Treatments for chronic diseases are changing fast as biologic drugs dominate pharmaceutical companies’ R&D pipelines. The shift in focus to biologic drugs increases the demand for more advanced drug delivery devices which meet the needs of patients and can cope with the properties of biologic drugs.
Introducing Plug & Play - the first wearable injector to fulfil the needs of patients and pharmaceutical companies, reshaping the wearable injector market with a novel approach to usability and technology
This content was originally posted on Cambridge Consultants' website. Cambridge Consultants develops breakthrough products, creates and licenses intellectual property and provides business consultancy in technology critical issues for clients worldwide. For more than 50 years, the company has been helping its clients turn business opportunities into commercial successes, whether they are launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies.
